Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding DE:ZSRN?
Track your performance easily
DE:ZSRN Price & Analysis
ZSRN ETF Chart & Stats
Day’s Range― - ―
52-Week Range€11.89 - €14.39
Previous Close€13.6
VolumeN/A
Average Volume (3M)1.22K
AUM103.93M
NAV13.51
Expense Ratio0.30%
Holdings Count61
Beta0.56
Inception DateJun 07, 2018
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume1,220
AlphaN/A
MSCI Emerging SRI S-Series PAB 5% Capped UCITS ETF EUR Capitalisation (ZSRN) Fund Flow Chart
MSCI Emerging SRI S-Series PAB 5% Capped UCITS ETF EUR Capitalisation (ZSRN) 1 year Net Flows: -€45M
ZSRN ETF News
ZSRN ETF FAQ
What was DE:ZSRN’s price range in the past 12 months?
DE:ZSRN lowest ETF price was €11.89 and its highest was €14.39 in the past 12 months.
What is the AUM of DE:ZSRN?
As of Nov 15, 2024 The AUM of DE:ZSRN is 103.93M.
Is DE:ZSRN overvalued?
According to Wall Street analysts DE:ZSRN’s price is currently Undervalued.
Does DE:ZSRN pay dividends?
DE:ZSRN does not currently pay dividends.
How many shares outstanding does DE:ZSRN have?
Currently, no data Available
Which hedge fund is a major shareholder of DE:ZSRN?
Currently, no hedge funds are holding shares in DE:ZSRN
Top 10 Holdings
U.S. Dollar
11.57%
BNP Paribas SA (UK)
8.83%
AXA SA (UK)
6.53%
Lanxess (OTC)
6.27%
Compagnie de Saint Gobain
5.69%
Credit Agricole SA (UK)
4.96%
Societe Generale (UK)
3.76%
Schneider Electric SE (UK)
3.56%
BNP Paribas InstiCash SICAV - BNP Paribas InstiCash USD 1D LVNAV I Capitalisation
3.50%
Knorr-Bremse AG
3.21%
Total57.87%
ETF Description
MSCI Emerging SRI S-Series PAB 5% Capped UCITS ETF EUR Capitalisation
The Fund seeks to replicate (with a maximum tracking error of 1%) the performance of the MSCI Emerging SRI S-Series PAB 5% Capped (NTR) index (Bloomberg: M7CXESC index) (the Index) by investing in a substitute basket, composed of, inter alia, shares of companies, debt securities or cash (synthetic replication).